You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
回盛生物(300871.SZ)披露上市安排:8月5日初步詢價 8月17日刊登發行結果
格隆匯 08-03 10:18

格隆匯8月3日丨回盛生物(300871.SZ)披露首次公開發行股票並在創業板上市初步詢價及推介公告,公司擬公開發行股票2770萬股,佔該次發行後公司股份總數的比例為25.07%。該次發行全部為新股發行,不涉及原股東公開發售股份。

其中,初始戰略配售發行數量為138.50萬股,佔該次發行數量的5.00%。回撥機制啟動前,該次發行網下初始發行數量為1842.05萬股,佔扣除初始戰略配售數量後發行數量的70.00%;網上初始發行數量為789.45萬股,佔扣除初始戰略配售數量後發行數量的30.00%。

初步詢價時間為8月5日的9:30-15:00,8月7日確定發行價格,8月10日網上路演,8月11日網上申購配號,8月17日刊登《發行結果公告》。公告顯示,公司網上、網下發行申購日為8月11日,8月13日將公佈中籤結果。

發行人股票簡稱為“回盛生物”,股票代碼為“300871”,該代碼同時用於本次發行的初步詢價、網上申購及網下申購。根據中國證監會《上市公司行業分類指引》(2012年修訂),回盛生物所屬行業為醫藥製造業(C27)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account